Itau Unibanco Holding S.A. Ultragenyx Pharmaceutical Inc. Transaction History

Itau Unibanco Holding S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$37.42 - $51.61 $6,286 - $8,670	168 New	168 $6,000
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $1,872 - $2,902	-59 Reduced 17.88%	271 $12,000
Q2 2023 Aug 14, 2023	SELL	$37.35 - $52.15 $634 - $886	-17 Reduced 4.9%	330 $15,000
Q4 2022 Feb 09, 2023	SELL	$33.72 - $46.33 $809 - $1,111	-24 Reduced 6.47%	347 $16,000
Q2 2022 Aug 15, 2022	BUY	$45.8 - $85.4 $10,671 - $19,898	233 Added 168.84%	371 $22,000
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $311 - $422	5 Added 3.76%	138 $10,000
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $12,972 - $15,463	-176 Reduced 56.96%	133 $11,000
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $623 - $819	8 Added 2.66%	309 $28,000
Q2 2021 Aug 17, 2021	BUY	$92.19 - $115.71 $27,749 - $34,828	301 New	301 $29,000

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.